Roger Albin is the Anne B. Young Collegiate Professor of Neurology at the University of Michigan, Associate Director for Research at VA Ann Arbor Health System Geriatrics Research, Education, and Clinical Center, and Director of the University of Michigan Udall Center. His primary research interest is the neurobiology of the clinical manifestations of basal ganglia disorders, notably Parkinson’s disease. With Drs. Anne Young and Jack Penney, he proposed the most influential model of basal ganglia dysfunction. Dr. Albin's past work includes both laboratory and clinical research on Parkinson’s disease, Huntington’s disease, and Tourette syndrome. His recent work focuses on treatment non-responsive features of Parkinson’s disease such as cognitive decline. This research uses state-of-the-art imaging methods to understand the changes in neurochemical systems driving these important features of Parkinson’s disease.
Associated Grants
-
-
Alpha4Beta2 Nicotinic Agonist for Treatment of L-Dopa Refractory Gait and Balance Disorders in Parkinson Disease
2015
-
Treating Early Cognitive Impairments and Associated Movement Control Deficits by Stimulating alpha4beta2* nAChRs
2010
-